Literature DB >> 949676

Radiation therapy and Corynebacterium parvum in the treatment of murine tumors.

H D Suit, R S Sedlacek, V Silobrcic, R M Linggood.   

Abstract

The relative effectiveness of local irradiation alone or combined with Corynebacterium parvum (C parvum) treatment has been investigated employing four tumors: a mammary carcinoma (MCa) (nonimmunogenic), a fibrosarcoma (moderately strongly immunogenic), and two squamous cell carcinomas (SCC-2 being weakly and SCC-4 being very weakly or nonimmunogenic). C parvum treatment was started when the isotransplanted tumor growing in the mouse leg was 5 mm in diameter and the local irradiation was administered to 8-mm diameter tumor. Effect of the combined treatment was barely evident with the MCa but strongly present in FSa; up to 60% of mice were cured of FSa by C parvum alone and the response to low radiation dose, e.g., 200 rads, was highly increased. For SCC-2 the TCD50 was approximately 7000 rads and 3000 rads in control and test mice, respectively. Comparable values for SCC-4 were 7700 and approximately 5500 rads. Importantly, for SCC-4 there was a large and highly significant reduction in the proportion of mice that died of metastases to lung but were free of evident tumor at the primary site.

Entities:  

Mesh:

Year:  1976        PMID: 949676     DOI: 10.1002/1097-0142(197606)37:6<2573::aid-cncr2820370602>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

Review 1.  The changing paradigm of tumour response to irradiation.

Authors:  Richard P Hill
Journal:  Br J Radiol       Date:  2016-08-02       Impact factor: 3.039

2.  The demonstration of in vivo misonidazole tumour toxicity using post radiation hypoxia.

Authors:  C J Gomer; R J Johnson; F W Hetzel; G Lawrence
Journal:  Br J Cancer Suppl       Date:  1978-06

3.  The effect of chemotherapy on occult metastases after surgical removal of a non-immunogenic mouse carcinoma.

Authors:  T Zebro; E A Wright
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

4.  CpG plus radiotherapy: a review of preclinical works leading to clinical trial.

Authors:  Kathy A Mason; Nancy R Hunter
Journal:  Front Oncol       Date:  2012-08-14       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.